Logo image of CLH

CLEAN HARBORS INC (CLH) Stock Fundamental Analysis

NYSE:CLH - New York Stock Exchange, Inc. - US1844961078 - Common Stock - Currency: USD

236.43  +2.26 (+0.97%)

After market: 236.43 0 (0%)

Fundamental Rating

5

CLH gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 84 industry peers in the Commercial Services & Supplies industry. CLH has an average financial health and profitability rating. CLH is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

CLH had positive earnings in the past year.
CLH had a positive operating cash flow in the past year.
In the past 5 years CLH has always been profitable.
Each year in the past 5 years CLH had a positive operating cash flow.
CLH Yearly Net Income VS EBIT VS OCF VS FCFCLH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M

1.2 Ratios

With a decent Return On Assets value of 5.17%, CLH is doing good in the industry, outperforming 67.86% of the companies in the same industry.
CLH's Return On Equity of 14.18% is fine compared to the rest of the industry. CLH outperforms 75.00% of its industry peers.
CLH's Return On Invested Capital of 7.62% is fine compared to the rest of the industry. CLH outperforms 63.10% of its industry peers.
The Average Return On Invested Capital over the past 3 years for CLH is below the industry average of 11.60%.
Industry RankSector Rank
ROA 5.17%
ROE 14.18%
ROIC 7.62%
ROA(3y)6.03%
ROA(5y)4.99%
ROE(3y)17.95%
ROE(5y)15.47%
ROIC(3y)8.67%
ROIC(5y)7.33%
CLH Yearly ROA, ROE, ROICCLH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15 20

1.3 Margins

CLH has a better Profit Margin (6.48%) than 73.81% of its industry peers.
CLH's Profit Margin has improved in the last couple of years.
The Operating Margin of CLH (10.96%) is better than 75.00% of its industry peers.
CLH's Operating Margin has improved in the last couple of years.
CLH has a Gross Margin (30.76%) which is in line with its industry peers.
In the last couple of years the Gross Margin of CLH has remained more or less at the same level.
Industry RankSector Rank
OM 10.96%
PM (TTM) 6.48%
GM 30.76%
OM growth 3Y7.87%
OM growth 5Y11.1%
PM growth 3Y8.55%
PM growth 5Y18.99%
GM growth 3Y-0.48%
GM growth 5Y0.63%
CLH Yearly Profit, Operating, Gross MarginsCLH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30

6

2. Health

2.1 Basic Checks

CLH has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
Compared to 1 year ago, CLH has about the same amount of shares outstanding.
The number of shares outstanding for CLH has been reduced compared to 5 years ago.
The debt/assets ratio for CLH is higher compared to a year ago.
CLH Yearly Shares OutstandingCLH Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
CLH Yearly Total Debt VS Total AssetsCLH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

CLH has an Altman-Z score of 3.41. This indicates that CLH is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of CLH (3.41) is better than 71.43% of its industry peers.
The Debt to FCF ratio of CLH is 7.39, which is on the high side as it means it would take CLH, 7.39 years of fcf income to pay off all of its debts.
CLH has a better Debt to FCF ratio (7.39) than 63.10% of its industry peers.
A Debt/Equity ratio of 1.02 is on the high side and indicates that CLH has dependencies on debt financing.
CLH's Debt to Equity ratio of 1.02 is on the low side compared to the rest of the industry. CLH is outperformed by 66.67% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.02
Debt/FCF 7.39
Altman-Z 3.41
ROIC/WACC0.95
WACC8.06%
CLH Yearly LT Debt VS Equity VS FCFCLH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

2.3 Liquidity

A Current Ratio of 2.45 indicates that CLH has no problem at all paying its short term obligations.
The Current ratio of CLH (2.45) is better than 78.57% of its industry peers.
CLH has a Quick Ratio of 2.07. This indicates that CLH is financially healthy and has no problem in meeting its short term obligations.
With an excellent Quick ratio value of 2.07, CLH belongs to the best of the industry, outperforming 84.52% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.45
Quick Ratio 2.07
CLH Yearly Current Assets VS Current LiabilitesCLH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

5

3. Growth

3.1 Past

The earnings per share for CLH have decreased by -1.79% in the last year.
Measured over the past years, CLH shows a very strong growth in Earnings Per Share. The EPS has been growing by 31.46% on average per year.
Looking at the last year, CLH shows a small growth in Revenue. The Revenue has grown by 5.49% in the last year.
Measured over the past years, CLH shows a quite strong growth in Revenue. The Revenue has been growing by 11.54% on average per year.
EPS 1Y (TTM)-1.79%
EPS 3Y26.79%
EPS 5Y31.46%
EPS Q2Q%-4.07%
Revenue 1Y (TTM)5.49%
Revenue growth 3Y15.67%
Revenue growth 5Y11.54%
Sales Q2Q%-0.18%

3.2 Future

The Earnings Per Share is expected to grow by 12.30% on average over the next years. This is quite good.
CLH is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.21% yearly.
EPS Next Y3.3%
EPS Next 2Y10.7%
EPS Next 3Y15.8%
EPS Next 5Y12.3%
Revenue Next Year3.82%
Revenue Next 2Y4.63%
Revenue Next 3Y5.38%
Revenue Next 5Y5.21%

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
CLH Yearly Revenue VS EstimatesCLH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2B 4B 6B 8B
CLH Yearly EPS VS EstimatesCLH Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 5 10

3

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 33.21, the valuation of CLH can be described as expensive.
CLH's Price/Earnings is on the same level as the industry average.
CLH's Price/Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 27.24.
With a Price/Forward Earnings ratio of 26.00, CLH can be considered very expensive at the moment.
Compared to the rest of the industry, the Price/Forward Earnings ratio of CLH is on the same level as its industry peers.
Compared to an average S&P500 Price/Forward Earnings ratio of 36.42, CLH is valued a bit cheaper.
Industry RankSector Rank
PE 33.21
Fwd PE 26
CLH Price Earnings VS Forward Price EarningsCLH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

CLH's Enterprise Value to EBITDA is on the same level as the industry average.
CLH's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 33.66
EV/EBITDA 13.51
CLH Per share dataCLH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60 80 100

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates CLH does not grow enough to justify the current Price/Earnings ratio.
CLH has a very decent profitability rating, which may justify a higher PE ratio.
CLH's earnings are expected to grow with 15.80% in the coming years. This may justify a more expensive valuation.
PEG (NY)10.06
PEG (5Y)1.06
EPS Next 2Y10.7%
EPS Next 3Y15.8%

0

5. Dividend

5.1 Amount

No dividends for CLH!.
Industry RankSector Rank
Dividend Yield N/A

CLEAN HARBORS INC

NYSE:CLH (8/4/2025, 8:04:00 PM)

After market: 236.43 0 (0%)

236.43

+2.26 (+0.97%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryCommercial Services & Supplies
Earnings (Last)07-30 2025-07-30/bmo
Earnings (Next)10-28 2025-10-28/bmo
Inst Owners93.22%
Inst Owner Change0.8%
Ins Owners5.57%
Ins Owner Change-4.8%
Market Cap12.67B
Analysts82.67
Price Target260.49 (10.18%)
Short Float %1.48%
Short Ratio2.31
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-0.54%
Min EPS beat(2)-2.32%
Max EPS beat(2)1.24%
EPS beat(4)2
Avg EPS beat(4)1.98%
Min EPS beat(4)-3.86%
Max EPS beat(4)12.88%
EPS beat(8)5
Avg EPS beat(8)1.75%
EPS beat(12)9
Avg EPS beat(12)4.09%
EPS beat(16)13
Avg EPS beat(16)10.5%
Revenue beat(2)0
Avg Revenue beat(2)-2.66%
Min Revenue beat(2)-3.74%
Max Revenue beat(2)-1.58%
Revenue beat(4)1
Avg Revenue beat(4)-1.58%
Min Revenue beat(4)-3.74%
Max Revenue beat(4)0.03%
Revenue beat(8)3
Avg Revenue beat(8)-1.3%
Revenue beat(12)6
Avg Revenue beat(12)-0.41%
Revenue beat(16)10
Avg Revenue beat(16)1.55%
PT rev (1m)1.14%
PT rev (3m)1.77%
EPS NQ rev (1m)0.59%
EPS NQ rev (3m)0.93%
EPS NY rev (1m)-0.22%
EPS NY rev (3m)1.03%
Revenue NQ rev (1m)0.06%
Revenue NQ rev (3m)-0.12%
Revenue NY rev (1m)-0.32%
Revenue NY rev (3m)-0.91%
Valuation
Industry RankSector Rank
PE 33.21
Fwd PE 26
P/S 2.13
P/FCF 33.66
P/OCF 16.83
P/B 4.67
P/tB 22.74
EV/EBITDA 13.51
EPS(TTM)7.12
EY3.01%
EPS(NY)9.09
Fwd EY3.85%
FCF(TTM)7.02
FCFY2.97%
OCF(TTM)14.05
OCFY5.94%
SpS110.91
BVpS50.65
TBVpS10.4
PEG (NY)10.06
PEG (5Y)1.06
Profitability
Industry RankSector Rank
ROA 5.17%
ROE 14.18%
ROCE 10.13%
ROIC 7.62%
ROICexc 8.55%
ROICexgc 13.72%
OM 10.96%
PM (TTM) 6.48%
GM 30.76%
FCFM 6.33%
ROA(3y)6.03%
ROA(5y)4.99%
ROE(3y)17.95%
ROE(5y)15.47%
ROIC(3y)8.67%
ROIC(5y)7.33%
ROICexc(3y)9.76%
ROICexc(5y)8.32%
ROICexgc(3y)16.3%
ROICexgc(5y)13.8%
ROCE(3y)11.52%
ROCE(5y)9.73%
ROICexcg growth 3Y10.92%
ROICexcg growth 5Y12.41%
ROICexc growth 3Y14.1%
ROICexc growth 5Y9.64%
OM growth 3Y7.87%
OM growth 5Y11.1%
PM growth 3Y8.55%
PM growth 5Y18.99%
GM growth 3Y-0.48%
GM growth 5Y0.63%
F-Score7
Asset Turnover0.8
Health
Industry RankSector Rank
Debt/Equity 1.02
Debt/FCF 7.39
Debt/EBITDA 2.55
Cap/Depr 86.82%
Cap/Sales 6.34%
Interest Coverage 4.19
Cash Conversion 69.4%
Profit Quality 97.81%
Current Ratio 2.45
Quick Ratio 2.07
Altman-Z 3.41
F-Score7
WACC8.06%
ROIC/WACC0.95
Cap/Depr(3y)108.74%
Cap/Depr(5y)95.27%
Cap/Sales(3y)7.36%
Cap/Sales(5y)6.97%
Profit Quality(3y)77.75%
Profit Quality(5y)110.67%
High Growth Momentum
Growth
EPS 1Y (TTM)-1.79%
EPS 3Y26.79%
EPS 5Y31.46%
EPS Q2Q%-4.07%
EPS Next Y3.3%
EPS Next 2Y10.7%
EPS Next 3Y15.8%
EPS Next 5Y12.3%
Revenue 1Y (TTM)5.49%
Revenue growth 3Y15.67%
Revenue growth 5Y11.54%
Sales Q2Q%-0.18%
Revenue Next Year3.82%
Revenue Next 2Y4.63%
Revenue Next 3Y5.38%
Revenue Next 5Y5.21%
EBIT growth 1Y1.33%
EBIT growth 3Y24.78%
EBIT growth 5Y23.92%
EBIT Next Year74.71%
EBIT Next 3Y27.96%
EBIT Next 5Y20.03%
FCF growth 1Y15.34%
FCF growth 3Y3.81%
FCF growth 5Y11.72%
OCF growth 1Y3.15%
OCF growth 3Y12.52%
OCF growth 5Y13.49%